Literature DB >> 20374182

Evaluation of renal oxidative stress in the development of DOCA-salt induced hypertension and its renal damage.

Behjat Seifi1, Mehri Kadkhodaee, Seyed M Karimian, Maryam Zahmatkesh, Jie Xu, Manoocher Soleimani.   

Abstract

To ascertain the onset of renal oxidative stress and its interrelation with the increase in blood pressure (BP) and kidney injury in rats subjected to Deoxycorticosterone (DOCA)-salt treatment, BP, renal antioxidants, renal damage indices, and histological changes were studied weekly. In the two other groups, 200 mg/kg/day vitamin E or C were co-administered with DOCA-salt for 4 weeks. Blood Pressure was increased at week one. Urinary N-acetyl-B-diglucosaminidase (NAG) and proteinuria increased and renal catalase decreased at 2nd week. Histological changes and decreased glothatione (GSH) and Ferric reducing antioxidant power (FRAP) were demonstrated at three week. Vitamin therapy increased renal antioxidants and decreased BP, NAG, proteinuria, and histological damage. Thus, elevation in BP precedes the onset of renal oxidative stress in DOCA-salt treated rats. Enhanced renal oxidative stress contributes to kidney damage. In this study, treatment with vitamin C or vitamin E preserved renal antioxidant levels, prevented renal damage, and partially inhibited elevation of BP in the DOCA-salt treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20374182     DOI: 10.3109/10641960902993111

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  10 in total

1.  Alpha-tocopherol ameliorates oxidative renal insult associated with spinal cord reperfusion injury.

Authors:  Mohamed D Morsy; Salah O Bashir
Journal:  J Physiol Biochem       Date:  2013-01-24       Impact factor: 4.158

2.  Angiotensin II Type 2-Receptor Agonist C21 Reduces Proteinuria and Oxidative Stress in Kidney of High-Salt-Fed Obese Zucker Rats.

Authors:  Sanket N Patel; Quaisar Ali; Tahir Hussain
Journal:  Hypertension       Date:  2016-03-28       Impact factor: 10.190

3.  Effect of morin, a flavonoid against DOCA-salt hypertensive rats: a dose dependent study.

Authors:  P Prahalathan; S Kumar; B Raja
Journal:  Asian Pac J Trop Biomed       Date:  2012-06

4.  Role of exogenous nitric oxide donor in treatment of decompensated hemorrhagic shock in normotensive and hypertensive rats.

Authors:  Majid Khazaei; Babak Barmaki
Journal:  J Biomed Biotechnol       Date:  2012-06-12

5.  Effects of hypertension on hemodynamic response and serum nitrite concentration during graded hemorrhagic shock in rats.

Authors:  Babak Barmaki; Ali Nasimi; Majid Khazaei
Journal:  J Res Med Sci       Date:  2011-09       Impact factor: 1.852

6.  The DOCA-Salt Hypertensive Rat as a Model of Cardiovascular Oxidative and Inflammatory Stress.

Authors:  Abishek Iyer; Vincent Chan; Lindsay Brown
Journal:  Curr Cardiol Rev       Date:  2010-11

7.  Tilapia viscera hydrolysate extract alleviates oxidative stress and renal damage in deoxycorticosterone acetate-salt-induced hypertension rats.

Authors:  Putut Har Riyadi; Mochammad Fitri Atho'illah; Wendy Alexander Tanod; Irma Sarita Rahmawati
Journal:  Vet World       Date:  2020-11-23

8.  Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism.

Authors:  Hua-Chun Weng; Xin-Yu Lu; Yu-Peng Xu; Yi-Hong Wang; Dan Wang; Yi-Ling Feng; Zhang Chi; Xiao-Qing Yan; Chao-Sheng Lu; Hong-Wei Wang
Journal:  Mol Med       Date:  2021-11-13       Impact factor: 6.354

9.  Pharmacological investigation of brucine anti-ulcer potential.

Authors:  Muhammad Noman; Neelum Gul Qazi; Najeeb Ur Rehman; Arif-Ullah Khan
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

10.  Characterization of musclin as a new target for treatment of hypertension.

Authors:  Jia-Wei Lin; Cheng-Chia Tsai; Li-Jen Chen; Ho-Shan Niu; Chen Kuei Chang; Chiang-Shan Niu
Journal:  Biomed Res Int       Date:  2014-03-09       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.